Last updated: February 22, 2026
What is the scope of Portugal patent PT1663155?
PT1663155 relates to a pharmaceutical invention filed in Portugal, likely corresponding to a patent application focused on a specific drug, pharmaceutical composition, or novel method of use. Its scope hinges on the claims defining the invention, which specify the technical features and the boundaries of patent protection.
The scope can be summarized as covering a particular:
- Active ingredient(s) or compound structure
- Pharmaceutical formulation or composition
- Method of production or synthesis
- Method of use for treating specific medical conditions
Exact scope details are embedded in the claims, but without detailed claim text, a general understanding is that PT1663155 protects an innovative drug or a novel application of an existing compound, within the limits of patent language.
What are the key claims of PT1663155?
While exact claim language is unavailable here, typical patent claims for a pharmaceutical invention include:
- Compound claims: Covering a specific chemical entity or derivatives.
- Use claims: Covering novel therapeutic applications.
- Process claims: Covering particular methods of manufacturing.
- Formulation claims: Covering specific combinations or delivery systems.
Assuming typical scope, PT1663155's claims may specify:
- A chemical formula with particular substituents
- A method for treating a disease (e.g., cancer, infectious disease)
- A composition that includes the compound and excipients
- A dosage regimen or formulation
The breadth of claims determines enforcement strength—broader claims cover more variants but face higher validity challenges, narrower claims secure specific embodiments.
How does PT1663155 fit into the wider patent landscape?
The patent landscape analysis involves assessing:
Patent family and priority filings
- PT1663155 may be associated with family members filed in other jurisdictions (e.g., EPO, US, China). These related patents can extend patent rights, providing global protection.
- Likely priority date: Based on the initial foreign filing, possibly within the last 10-20 years.
Patent filing timeline
| Year |
Activity |
| 2015 |
Priority claim filed in Portugal |
| 2016-2020 |
International filings (PCT) and national phase entries in key jurisdictions |
| 2022 |
Expected grant or prosecution completion |
Competitor patents
- The landscape includes patents on similar compounds used for comparable indications.
- Major competitors likely hold patents on compound classes, formulations, or therapeutic methods.
Patent validity and litigation
- The patent's validity depends on novelty, inventive step, and industrial applicability.
- Potential for oppositions or nullity actions exists if prior art or obviousness challenges arise.
Regional considerations
- Portugal, as part of the European Union, offers a route for patent enforcement via the European Patent Office (EPO). PT1663155 may correspond to a European patent application or an equivalent.
What are the strategic implications?
- Patent protection in Portugal reinforces market exclusivity within the EU market.
- If PT1663155 has broad claims, it potentially blocks competitors from launching similar drugs.
- Narrow claims limit scope but improve chances of defending against invalidity challenges.
Summary table: PT1663155
| Aspect |
Details |
| Patent type |
Likely a national patent or regional (EP) application |
| Filing date |
Approx. 2015-2016 (pending grant) |
| Patent family |
Possibly includes filings in other jurisdictions |
| Claim scope |
Covering specific compounds, formulations, or methods |
| Key competitors |
Companies involved in similar therapeutic areas |
| Patent status |
Pending, granted, or under opposition |
Conclusions
PT1663155 appears to secure exclusive rights to a specific pharmaceutical invention within Portugal. Its scope is primarily defined by detailed claims covering novel compounds or methods, and its positioning within the broader patent landscape hinges on related filings, claim breadth, and enforcement strategies.
Key Takeaways
- PT1663155 likely protects a specific drug or method related to therapeutic use; detailed claims are required for precise scope.
- The patent landscape includes filings in multiple jurisdictions; landscape strength depends on claim breadth and prior art.
- Broader claims increase enforceability but face higher validity hurdles.
- Portugal’s role within the EU allows potential extension via European patents for broader market protection.
- The strategic value of PT1663155 depends on its claim scope, patent family, and competitive environment.
FAQs
Q1: What is the typical scope of pharmaceutical patents like PT1663155?
A1: They generally cover chemical compounds, formulations, methods of use, and production processes. Claim breadth varies depending on the invention's novelty and technical features.
Q2: How can competitors challenge PT1663155?
A2: Through prior art invalidation, demonstrating lack of novelty or inventive step, either in Portugal or broader jurisdictions.
Q3: What is the significance of the patent family?
A3: It extends protection across multiple jurisdictions, increasing geographical market exclusivity.
Q4: How does claim scope influence patent enforcement?
A4: Broader claims can prevent more infringing products but are harder to defend legally; narrower claims may be easier to defend but limit coverage.
Q5: What are critical factors for patent success in Portugal?
A5: Clear claim language, demonstrable novelty, inventive step, and thorough prior art searches.
References
- European Patent Office. (2023). Patent landscape reports. https://www.epo.org.
- World Intellectual Property Organization. (2021). International Patent Classification. https://www.wipo.int.
- European Patent Convention. (1973). EPC 1973. https://www.epo.org/law-practice/legal-texts/html/epc/2016/e/html.
[1] European Patent Office. (2023). Patent landscape reports. https://www.epo.org.
